|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Efficacy of gefitinib,an inhibitor of the epidermal growth factor receptor tyrosine kinase,in symptomatic patients with non-small-cell lung cancer:a randomized trial显示文摘 | Kris MG Natale RB Herbst RS | 2003 | JAMA2003，290，16： | 1 |
| 2 | Gemcitabine and nonplatinum combination in non small- cell lung cancer 显示文摘 | Natale RB | 2001 | Oncology ( Huntingt )2001，15，6： | 1 |
| 3 | Improvement in symptoms and quality of life for advanced non-small-cell lung cancer patients receiving ZD1839 (Iressa) in IDEAL 2显示文摘 | Natale RB Skarin AT Maddox AM | 2002 | Proc Annu Meet Am Soc Clin Oncol2002，21，： | 1 |
| 4 | Overview of current and future chemotherapeutic agents in non-small cell lung cancer 显示文摘 | Natale RB | 1997 | Semin Oncol1997，24，27： | 1 |
| 5 | Quantitative gene expression in non-small cell lung cancer from paraffin-embedded tissue specimen: predicting response to gefitinib, an EGFR kinase inhibitor显示文摘 | Natale RB | 2003 | Lung Cancer2003，41，2： | 1 |
| 6 | Randomized phase Ⅲ trial comparing cisplatin/etoposide versus arboplatin/paclitaxel in adbanced and metastatic non-small cell lung cancer (NSCLC)显示文摘 | Belani CP Natale RB Lee JS | 1998 | Proc Am Soc Clin Oncol1998，17，1751： | 1 |
| 7 | Efficacy and safety of single- agent pertuzumab, a human epidermal receptor dimerization inhibitor, in patients with non small cell lung cancer显示文摘 | Herbst RS Davies AM Natale RB | 2007 | Clin Cancer Res2007，13，20： | 1 |
| 8 | PhaseⅢtrial of vandetanib compared with erlotinib in patients with previously treated advanced non-small-cell lung cancer显示文摘 | Natale RB Thongprasert S Greco FA | 2011 | J Clin Oncol2011，29，8： | 1 |
| 9 | Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small-cell lung cancer a randomized trial显示文摘 | KRIS MG NATALE RB HERBST RS | 2003 | JAMA2003，290，16： | 1 |
| 10 | Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial显示文摘 | Kris MG Natale RB Herbst RS Lynch TJ | 2003 | JAMA2003，290，： | 1 |
| 11 | Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small-cell lung cancer显示文摘 | KRIS MG NATALE RB HERBST RS | 2003 | JAMA2003，290，16： | 1 |
| 12 | Phase m trial of vandetanib compared with erlotinib in patients with previously treated advanced non-small-cell lung cancer 显示文摘 | Natale RB Thongprasert S Greco FA | 2011 | J Clin Oncol2011，29，8： | 1 |
| 13 | Efficacy of gefitinib,an inhibitor of the epidermal growth factor receptor tyrosine kinase,in symptomatic patients with non-small cell lung cancer:a randomized trial显示文摘 | Kris MG Natale RB Herbst RS | 2003 | JAMA2003，290，16： | 1 |
| 14 | Phase Ⅲ trial of vandetanib compared with erlotinib in patients with previously treated advanced non-small-cell lung cancer 显示文摘 | Natale RB Thongprasert S Greco FA | 2011 | J Clin Oncol2011，29，8： | 1 |
| 15 | Efficacy of gefitinib,aninhibitor of the epidermal growth factor receptor tyrosine kinase,in symptomatic patients with non-small cell lung cancer:arandomized trial显示文摘 | Kris MG Natale RB Herbst RS | 2003 | JAMA2003，290，16： | 1 |
| 16 | Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non - small cell lung cancer: a randomized trial显示文摘 | Kris MG Natale RB Herbst RS el al | 2003 | JAMA2003，290，16： | 1 |
| 17 | Efficacy of gefitinib, aninhibitor of the epidermal growth factor receptor tyrosine kinase, insymptomatic patients with non-small cell lung cancer: a randomizedtrial显示文摘 | Kris MG Natale RB Herbst RS | 2003 | JAMA2003，290，16： | 1 |
| 18 | Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer显示文摘 | Grossman HB Natale RB Tangen CM | 2003 | N Engl J Med2003，349，9： | 1 |
| 19 | A Phase Ⅱ trial of ZD1839(‘Iressa') in advanced non-small-cell lung cancer ( NSCLC )patients who had failed platinum-and docetaxel -based regimens (IDEAL 2) 显示文摘 | Kris MG Natale RB Herbst RS | 2002 | Proc Am Soc Clin Oneol2002，21，29： | 1 |
| 20 | Randomized phase Ⅲ trial comparing cisplatin/etoposide versus carboplatin/paclitaxel in advanced and metastatic non-small-cell lung cancer(Meeting Abstr)显示文摘 | Belani CP Natale RB Lee JS | 1998 | Proc Am Soc Clin Oncol1998，17，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员